Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 6 | 108643836 | intron variant | G/A | snv | 0.52 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Infections | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Infections | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Infections | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Infections | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Infections | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Infections | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Infections | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Infections; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.120 | 6 | 108652895 | intron variant | C/T | snv | 0.55 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.120 | 6 | 108652895 | intron variant | C/T | snv | 0.55 |
|
Respiratory Tract Diseases; Immune System Diseases; Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 6 | 108591998 | intron variant | T/C | snv | 0.17 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 6 | 108564420 | intron variant | C/T | snv | 0.30 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.882 | 0.120 | 6 | 108620265 | intron variant | A/C;G | snv |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||||||
|
0.882 | 0.120 | 6 | 108620265 | intron variant | A/C;G | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||||||
|
0.882 | 0.120 | 6 | 108620265 | intron variant | A/C;G | snv |
|
0.010 | 1.000 | 1 | 2020 | 2020 | |||||||||
|
0.882 | 0.120 | 6 | 108620265 | intron variant | A/C;G | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 |